MedPath

The feasibility study for lung cancer screening by novel urinary biomarker using protein fragments: a cross-sectional study

Not Applicable
Recruiting
Conditions
ung cancer
Registration Number
JPRN-UMIN000037032
Lead Sponsor
niversity of Miyazaki
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients who have multiple nodular shadows(more than or equal to 0.5cm) and/or multiple mass shadows clinicaly suspected tumor metastasis and/or pleural effusion by high resolution CT within 3 months. 2)Patients who have proteinuria, positive urine sugar or urine occult blood in urinalysis (more than or equal to 2+). 3)Patients who have renal dysfunction (Serum levels of creatinine > 2.0 mg/dl). 4)Patients who have alcohol or drug dependence or who are suspected to have alcohol or drug dependence. 5)Patients who is pregnant or who is suspected to be pregnant. 6)Patients who was enrolled another clinical trial and was prescribed a study drug within one month. 7)Patients whose attending physicians consider to be inappropriate for this study.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath